Max Rubin

Max is one of the Founders of Cambridge Healthcare Research. He has played a leading role in developing multiple client relationships and setting the standards and practices the company is known for today. As a Director of the Board, Max is responsible for the company’s strategic direction and overall governance.

Max is an experienced consultant with a broad background in strategic consulting and the pharmaceutical industry. He has led projects supporting pharmaceutical and biotechnology companies in a wide range of commercial strategy issues, including forecasting, market assessments, competitive threat analysis, and launch planning. Max’s client work has encompassed multiple therapeutic areas, amongst them neurology, endocrinology, hematology, vaccines, and regenerative medicine.

Max holds an MBA from the University of Cambridge and a BSc in Biotechnology from Tel Aviv University. Prior to CHR, he was a Senior Consultant and Engagement Manager at a life science consultancy and a Project Manager at Teva Pharmaceuticals.